Renaissance Capital logo

Co-Diagnostics Priced, Nasdaq: CODX

Commercializing diagnostic equipment for DNA tests.

Industry: Health Care

First Day Return: -3.2%

Co-Diagnostics is a molecular diagnostics company that has developed and intends to manufacture and sell reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), and to sell diagnostic equipment from other manufacturers as self-contained lab systems. We will either sell or lease our portable labs to existing diagnostic centers, through sale or lease agreements, and sell the reagents that comprise our proprietary tests.

Co-Diagnostics (CODX) Performance

Created with Highcharts 10.3.2Chart context menuCODX vs. IPO Index (IPOUSA)Jan 2018Jul 2018Jan 2019Jul 2019Jan 2020Jul 2020Jan 2021Jul 2021Jan 2022Jul 2022Jan 2023Jul 2023Jan 2024Jul 2024Jan 2025Jul 20250%+ 100%+ 200%-100%+ 300%View 5 days5dView 1 month1mView 3 months3mView year to dateYTDView 1 year1yView allAllRenaissance IPO IndexOur ETF tracks the IPO Index